Spending on antineoplastic agents in the United States: 2011-2016.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.6618
Abstract: 6618Background: Novel antineoplastic therapies confer advantages in efficacy and safety over traditional cytotoxic agents, but they are costly. There is little information on recent trends in actua... read more here.
Keywords: agents united; spending antineoplastic; 2011 2016; antineoplastic agents ... See more keywords